PharmNXT Biotech

What PharmNXT Biotech does

PharmNXT Biotech LLP is an India-headquartered (Thane, Maharashtra) manufacturer of single-use bioprocessing equipment and consumables serving biopharmaceutical and pharmaceutical manufacturers. The company's core offering spans three product categories: bioprocess equipment (NXTmix magnetic levitation-based mixers, NXTchrom chromatography systems, NXTtff tangential flow filtration, NXTmfilt virus filtration, NXTibps buffer preparation), containment solutions (NXT Rigid-N and Flex-N isolators, NXTvalve split butterfly valves, Xelta CB and XELTA Pac powder charging bags), and single-use technologies (XELTA 2D and 3D storage bags, NXTstor/NXTbin containers, NXTrack systems, XELTA KoNXT assemblies, XELTA LINR liners, and the DTR tubing management system acquired in mid-2025). The proprietary NXTmix levitation-based mixing technology, which eliminates bearings and seals to reduce particle shedding for shear-sensitive biologics, is a notable differentiator and is registered as intellectual property.

The business operates an enterprise field sales model with regional offices in India (Thane headquarters, Pune EkUse manufacturing facility), Singapore (South East Asia headquarters covering six countries), and South Korea (Incheon branch). Revenue is generated through two streams: capital equipment and consumables sales (single-use bags, mixers, filtration, containment) and professional services including installation, IQ/OQ qualification, preventive maintenance, spare parts, and process engineering consultancy for tech transfer from process development to manufacturing. A key value proposition is cost-competitive India-based manufacturing of cGMP-compliant single-use consumables, explicitly positioned as a response to the COVID-era supply chain vulnerability where global suppliers prioritized home markets. The company has assembled a 10+ partner ecosystem (SaniSure, Single Use Support, Ecolab, Entegris, Univercells, Vectron, Sexton, Verdot, Sunflower Therapeutics, Sani Membrane) covering the full bioprocessing value chain from expression vectors through fill-finish.

Target customer segments include biopharmaceutical manufacturers producing monoclonal antibodies, vaccines, gene therapies, cell therapies, mRNA therapeutics, and biosimilars; pharmaceutical manufacturers handling high-potency APIs (HPAPIs) requiring OEB 4 containment; and process development teams and CDMOs requiring consultancy, equipment sizing, and tech-transfer support. Documented regulatory compliance spans ISO 9001:2015, USP <85>, <87>, <88>, and <661.1>, FDA 21 CFR Part 11, and ISO 13485 across product lines. The company was founded in 2019 by Ankush Kapoor (CEO) and Sachin Joshi (Managing Director), and received the BioSpectrum India Excellence Awards 2025 "Top Emerging Biotech Company for Sustainable SUT Innovation" recognition. No funding rounds are disclosed in the available source material, indicating bootstrap or founder-funded growth.

Name

PharmNXT Biotech

Legal name

PharmNXT Biotech LLP

Website

https://pharmnxtbiotech.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

51–100 employees

Short description

PharmNXT Biotech manufactures single-use bioprocessing equipment and consumables, including mixing bags, storage bags, filtration, chromatography, and containment systems, serving biopharmaceutical and pharmaceutical manufacturers across India, South East Asia, and South Korea.

Ownership category

akta.pro rank

Headquarters

HQ city

Thane

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Single-Use Equipment and Consumables Sales: PharmNXT generates revenue through the manufacture and sale of single-use bioprocessing equipment and consumables including mixing bags (NXTmix, XELTA Mix), storage bags (XELTA 2D, XELTA 3D, XELTA LINR), containment solutions (isolators, powder handling bags), process equipment (chromatography, TFF, filtration), and tubing management systems (DTR). The company sells both equipment (capital expenditure) and consumables (recurring revenue).
2. Process Engineering and Consultancy Services: Post-sales services including equipment installation, qualification and documentation (IQ/OQ), preventive maintenance, diagnosis and repairs, spare parts supply, and process engineering consultancy covering process development, mass balance calculations, equipment sizing, and tech transfer from PD to manufacturing.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

PharmNXT Biotech manufactures single-use bioprocessing equipment and consumables for biologics manufacturing, including mixing systems (NXTmix MagLev mixers), storage bags (XELTA 2D/3D), chromatography and filtration systems, containment isolators, powder transfer valves, and tubing management systems (DTR). The company also provides post-sales process engineering services covering installation, qualification (IQ/OQ), preventive maintenance, spare parts, and process consultancy for tech transfer from PD to manufacturing scale.

Product overview

PharmNXT Biotech is a global bioprocessing solutions provider offering a comprehensive portfolio of high-quality equipment, consumables, and technical expertise for biologics manufacturing. The product portfolio consists of three main categories: (1) Bioprocess Equipment including NXTmix (levitation-based mixing from 50L-2000L), NXTchrom (chromatography systems), NXTtff (tangential flow filtration), NXTmfilt (virus filtration), and NXTibps (buffer preparation); (2) Containment Solutions including NXT Rigid-N (negative pressure rigid isolators), NXT Flex-N (flexible isolators), NXTvalve SBV (split butterfly valves for powder transfer), Xelta CB and XELTA Pac (powder charging bags); and (3) Single-Use Technologies including XELTA 2D and 3D storage bags, NXTstor and NXTbin containers, NXTrack systems, XELTA KoNXT and XELTA Mix assemblies, XELTA LINR liners, and DTR (Defined Tubing Routing) tubing management systems. The company also provides process consultancy and equipment services (installation, qualification, validation, and AMC). Products are supported by process flow solutions for Biosimilars, mRNA, Gene Therapy, and Cell Therapy applications.

Differentiator

Problem solved

Functional benefit

Brands

• NXT-Gen Technology: Technology platform encompassing bioprocess equipment, containment solutions, and single-use technologies including NXTchrom, NXTtff, NXTmfilt, NXTmix, NXTibps, NXTvalve, NXTrack, NXTstor, NXTbin
• XELTA
• EkUse
• DTR (Defined Tubing Routing)

Products and services

• NXTmix Next-generation magnetic levitation-based mixing system for single-use mixing requirements from media and buffer preparation to final formulation and filling. Eliminates bearings and seals, reducing particle shedding and enabling gentle mixing for shear-sensitive biopharmaceutical products. Available in volumes from 50L to 2000L, used by biopharmaceutical manufacturers.
• NXTchrom Configurable chromatography systems designed for purification processes in biologics manufacturing, compatible with all column diameters and offering a scalable platform for downstream processing. Used by biopharma manufacturers for monoclonal antibody, vaccine, and gene therapy purification.
• NXTtff Tangential flow filtration system for fully automated UF/DF (ultrafiltration/diafiltration) processes, handling volumes between 20L and 500L with low hold-up volume. Used by biopharmaceutical manufacturers for concentration and buffer exchange steps.
• NXTmfilt Automated bioprocessing system for virus filtration and particle removal, providing flexible solutions for sterile filtration, clarification, and bioburden reduction in biomanufacturing. Used by biologics manufacturers for critical filtration steps.
• NXTibps (Buffer Preparation System) Transformative buffer preparation system that addresses resource-intensive buffer preparation challenges as biomanufacturing capacity scales, used by biologics manufacturers to streamline buffer management operations.
• NXT Rigid-N Negative pressure rigid wall isolator system for low OEL (Occupational Exposure Limit) containment in pharmaceutical, biotechnology, and formulation industries, protecting processes from operators and the surrounding environment.
• NXT Flex-N Cost-effective flexible film isolator for high-quality containment and isolation of pharmaceutical applications, achieving nanogram containment levels. Retrofittable to existing equipment, used by pharmaceutical manufacturers for HPAPI handling.
• NXTvalve SBV (Split Butterfly Valve) Purpose-engineered split butterfly valve for safe, contained, and efficient powder transfer in pharmaceutical, biopharmaceutical, and chemical manufacturing. Available in sizes 2", 3", 4", 6", and 8" with OEB 4 containment level (1-10 µg/m³). Features active and passive disc halves with metal-to-metal sealing.
• Xelta CB (Powder Charging Bag) Fully integrated single-use powder charging bag with cost-effective 2D design, high strength and durability, manufactured using pharma-grade antistatic film, available in sizes 1L to 40L for contained powder transfer.
• XELTA Pac (3D Powder Charging Bag) Completely unified 3D single-use powder charging bag with cost-effective 3D design, high strength and durability, manufactured using pharma-grade antistatic LLDPE film for large-scale contained powder handling in pharmaceutical and biopharmaceutical manufacturing.
• XELTA 2D Storage Bags 2D storage bags for biopharmaceutical applications, manufactured from premium film with 0.325mm thickness, validated for pharmaceutical manufacturing processes under cGMP. Compliant with pharmacopoeia standards including USP <85>, USP <87>, USP <88>, and USP <661.1>. Available in volumes from 50ml to 50L.
• XELTA 3D Storage Bags 3D storage bags designed for large-scale biopharmaceutical applications, manufactured from premium film and validated for pharmaceutical manufacturing processes. Available in volumes from 100L to 1000L, featuring state-of-the-art design that improves robustness of single-use systems.
• NXTstor Stainless steel container for safe and reliable storage of biopharmaceutical fluids using XELTA 3D single-use bags, available in four volumes: 100L, 200L, 500L, and 1000L. Provides robust outer shell combined with disposable inner bag.
• NXTbin Stainless steel cylindrical vessel for safe storage of pharmaceutical or biopharmaceutical fluids using XELTA 3D single-use bags, available in three volumes: 100L, 200L, and 500L. Used in combination with XELTA LINR liners.
• NXTrack Mobile rack systems for efficient, ergonomic, and scalable handling of containers used in bio-production. Designed to reduce operator error and improve process efficiency for single-use technology operations.
• XELTA KoNXT (Single-Use Assemblies) Customized single-use assemblies designed per customer process needs, eliminating operator error and reducing contamination risk with proven flexible connections for fluid transfer applications in biomanufacturing. Designed under ISO 9001:2015 certified Quality Management System.
• XELTA Mix (Single-Use Mixing Bags) Single-use mixing bags designed for large-scale bioprocess applications where systems require reliability, flexibility, and easy installation. Manufactured from premium validated film, used in combination with NXTmix mixing systems.
• XELTA LINR (Open Single-Use Liners) Open single-use liner solution composed of multi-layer film optimized for NXTbin and other tanks, with 0.25mm film thickness, available in 100L, 200L, and 500L volumes. Gamma irradiation sterilization at 25-50 KGy. Validated for biopharmaceutical manufacturing.
• DTR (Defined Tubing Routing) Innovative modular tubing management system for cGMP single-use applications. Reduces trip hazards, defines tubing routes, and reduces risk of error in single-use assemblies. Available in sizes DTR6 through DTR35 with custom spans up to 2.9 meters. Acquired from Ireland-based Defined Tubing Routing in mid-2025.
• Process Engineering Services End-to-end post-sales services including equipment installation, qualification and documentation as per regulatory requirements, critical spares determination, diagnosis and repairs, spare parts supply, and preventive maintenance activities. Used by biopharma manufacturers to maintain and validate installed equipment.
• Process Consultancy Consultancy services for process development, mass balance calculations, automation strategy definition, equipment sizing, facility fit assessments, and tech transfer from process development (PD) to manufacturing scale. Targeted at biopharma manufacturers and CDMOs.

Quantifiable outcome

• COVID-19 supply chain disruption led Indian vaccine manufacturers to turn to PharmNXT for single-use bags when global suppliers prioritized home markets
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature12 records

Partnerships

Ten partnerships are on record, tiered core.

• SaniSurecoreTechnology or IntegrationSaniSure is a global leader in simplifying single-use systems for sterile drug and vaccine manufacturing. The partnership provides PharmNXT customers access to SaniSure's integrated portfolio of single-use technology products including Mixed4 mixing platforms, RC-40 roller bottle systems, and Cap2v8 bottle solutions. SaniSure combines multiple SUT companies (Cellon, Silicone Altimex, TBL Performance Plastics, GL Engineering, Sani-Tech West) with 6 manufacturing sites for vertical integration.
• Single Use SupportcoreTechnology or IntegrationSingle Use Support provides innovative fluid management products including bioprocess containers, single-use assemblies, RoSS Shell bag protection, RoSS.pFTU freeze-thaw platforms, RoSS.FILL aseptic filling systems, and RoSS.SHIP cold chain shipping solutions. Partnership enables PharmNXT to offer comprehensive single-use fluid management solutions.
• EntegriscoreTechnology or IntegrationEntegris, founded in 1966, provides Aramus single-use 2D bag assemblies made from high-grade gamma-stable fluoropolymer for critical process fluids and final products. Partnership expands PharmNXT's single-use bag portfolio with ultra-high purity offerings.
• Univercells TechnologiescoreTechnology or IntegrationUnivercells Technologies provides innovative biomanufacturing technologies including NevoLine Upstream Platform for cost-effective viral production and Scale-X fixed-bed bioreactor systems (hydro, carbo, cell collect) for viral vaccine, gene therapy, and oncolytic virus production. Partnership enables PharmNXT to offer intensified upstream bioprocessing solutions.
• VectroncoreTechnology or IntegrationVectron designs tailored expression vectors for optimal recombinant protein production in microbial hosts. Products include VB Expression (Pm/XylS modular expression platform), VB Evolution (evolution-based vector optimization), and VB Secretion (flagellum-based protein secretion system). Partnership enables PharmNXT to offer upstream vector design capabilities.
• Sexton BiotechnologiescoreTechnology or IntegrationSexton Biotechnologies (part of BioLife Solutions) provides cell and gene therapy products including AF-500 automated fill and seal system, Signata CT-5 automation platform, CellSeal cryogenic vials, and Stemulate/nLiven/T-Liven human platelet lysate products. Partnership enables PharmNXT to offer comprehensive cell and gene therapy manufacturing solutions.
• VerdotcoreTechnology or IntegrationVerdot, established 1950 and headquartered in Riom France, provides downstream bioprocessing solutions including InPlace chromatography columns, FlexiPro TFF systems, and FlexiPro Chrom systems for purification of monoclonal antibodies, vaccines, viral vectors (AAV, lentivirus), and mRNA therapeutics. Partnership extends PharmNXT's downstream processing portfolio.
• Sunflower TherapeuticscoreTechnology or IntegrationSunflower Therapeutics provides fully automated and integrated protein manufacturing platforms including Daisy Petal (1L perfusion fermentation system) and Dahlia Petal (15L perfusion fermentation system) with HelianthOS cloud-based automation. Partnership enables PharmNXT to offer modular, scalable bioproduction platforms.
• Sani MembranecoreTechnology or IntegrationSani Membrane provides Vibro Membrane Filtration (VMF) technology using low-shear vibration mechanism for membrane filtration. Product line spans Vibro-Lab35P (small-scale screening), Vibro-Lab280 (process development), Vibro-Lab3500 (scale-up), and Vibro-I (industrial production) for pharmaceutical filtration applications.
• EcolabcoreTechnology or IntegrationEcolab provides cleaning, disinfection, and contamination control solutions including Klercide products, Bioquell hydrogen peroxide vapor systems, Praesto chromatography resins (AP+, SP, Q series), and water treatment solutions for biopharmaceutical manufacturing. Partnership enables PharmNXT to offer comprehensive cleanroom and process cleaning solutions.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Sartorius AG: Sartorius is a global leader in bioprocessing, offering single-use bioreactors, mixing, storage, filtration, and fluid management solutions for biologics manufacturing—directly overlapping PharmNXT's NXT-Gen catalog across upstream and downstream workflows.
• Cytiva (Danaher): Cytiva, formerly GE Healthcare Life Sciences, supplies single-use bioreactors, mixing systems, chromatography columns, filters, and consumables to global biopharma, and competes head-to-head with PharmNXT across the full bioprocessing workflow.
• Merck KGaA (MilliporeSigma): MilliporeSigma's BioProcessing business offers Mobius single-use systems, Prostak filters, chromatography resins, and process equipment that closely mirror PharmNXT's NXTmix, NXTtff, NXTchrom, and XELTA consumable lines.
• Pall Corporation (Danaher): Pall's Allegro single-use bioprocess solutions—including mixers, storage systems, and filters—directly compete with PharmNXT's XELTA 2D/3D bags, NXTmix, and NXTmfilt product lines for biopharma manufacturing customers.
• Avantor: Avantor supplies single-use bioprocess solutions, fluids, and bioproduction materials to global biopharma, with overlapping product categories in mixing, storage, and filtration consumables that compete with PharmNXT's XELTA and NXT product families.
• Eppendorf: Eppendorf offers bioprocess solutions including single-use bioreactors (BioFlo), controllers, and mixing systems for cell culture and microbial fermentation, overlapping with PharmNXT's upstream equipment portfolio.
• SaniSure: SaniSure is a vertically integrated single-use technology provider (assembled from Cellon, Silicone Altimex, TBL, GL Engineering, Sani-Tech West) offering bags, mixing, and assemblies—directly comparable to PharmNXT's XELTA and NXTmix product lines, and currently a partner.

Broad incumbents

• Thermo Fisher Scientific: Through its BioProduction and Patheon businesses, Thermo Fisher offers single-use bioprocess containers, mixing systems, and CDMO services, positioning it as a broad incumbent with overlapping capabilities to PharmNXT's equipment, consumables, and process consultancy offerings.

Others

• Entegris: Entegris is both a PharmNXT partner and an adjacent supplier of Aramus fluoropolymer single-use 2D bags and high-purity fluid handling components for biopharma—representing an enabling ecosystem participant with overlapping customer accounts.

Emerging players

• PBS Biotech: PBS Biotech is a smaller, single-use-focused bioprocessing company offering vertical-wheel single-use bioreactors for cell and gene therapy applications—an emerging peer with partial overlap to PharmNXT's gene and cell therapy process flow offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/PharmNXT-Biotech-100078932983523
• LinkedInlinkedin.com/company/pharmnxt-biotech

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmNXT Biotech